IPCA Labs says USFDA removes import alert exemption on hydroxychloroquine sulphate

Ipca Laboratories on Thursday (2 July) said that US drug regulator has is removing the exemption given to the drug maker from the import alert for API and formulation of hydroxychloroquine sulphate.